昌吉哪里有泌尿医院昌吉博爱医院做无痛上环多少钱,昌吉包皮包茎切割手术费用,昌吉做无痛人流一共得多少钱,昌吉男科更好的医院,做流产术到好的医院昌吉,昌吉怀孕多久能测出来是否怀孕,昌吉哪里的妇科打掉孩子医院专业

Wall Street is worried about a trade war.The Dow dropped 420 points on Thursday after President Trump said his administration will impose tariffs on steel and aluminum imports. The Nasdaq and the S&P 500 declined 1.3% apiece.Trump's controversial tariff announcement caught investors off guard and immediately raised concerns about retaliation from China or other major U.S. trading partners."This is the first shot across the bow over a trade war," said Art Hogan, chief market strategist at B. Riley FBR. "And nobody wins a trade war."Trump said his administration would impose a 25% tariff on steel imports and a 10% tariff on aluminum. It was not immediately clear whether Trump would exempt some countries from the tariffs, as his national security advisers have urged him to do to avoid hurting U.S. allies.Corporate America has warned Trump that tariffs could backfire. Last month, the Business Roundtable warned of the risk of "foreign retaliation" that would "harm the U.S. economy."Investors will be looking to see how U.S. trading partners react to the tariffs.Beyond worries about retaliation, the tariff news drove concerns about rising costs for companies that rely heavily on aluminum and steel, like auto and plane makers. Imports make up about a third of the steel American businesses use every year, and more than 90% of aluminum used here. Shares of Boeing fell 3% General Motors dipped 4%, and Ford dropped 3%.Related: NY Fed chief: Tariffs risk 'trade war'If the tariffs result in higher prices on steel and aluminum, companies that rely on those products may pass on some of the costs to consumers. That raises the specter of creeping inflation."This clearly will [lead to] higher prices in the production chain, which is part of the inflation path," said Quincy Krosby, chief market strategist at Prudential Financial.The timing of the tariff news surprised Wall Street. A formal announcement was expected at some point Thursday, but then it was called off. Later, Trump mentioned his tariff plans in a hastily arranged listening session with steel and aluminum executives. And he didn't provide crucial details, such as whether certain countries will be exempted.Concerns about trade come at an already shaky time on Wall Street. The S&P 500 and Dow fell about 4% in February, their worst month in two years. Fears about inflation and soaring bond yields caused a surge in volatility, including two 1,000-point plunges for the Dow.The market had come back as investors focused on the strong economy and booming corporate profits. But stocks fell sharply again on Tuesday and Wednesday, putting the Dow is back in negative territory for the year.Turbulence has picked up as well. The VIX volatility index spiked 15% on Thursday. Selling pressure will climb as volatility increases, Krosby said.At least two corners of the stock market cheered Trump's tariff announcement. U.S. Steel and AK Steel soared 6% and 10%, respectively.Century Aluminum also spiked 7%. Another major aluminum maker, Alcoa, gained 1%.Trump's tariff moves could force investors to confront another trade issue: NAFTA. Trump has repeatedly threatened to tear up this major trade deal with Canada and Mexico. Talks to renegotiate NAFTA, a major piece of the U.S. economy, have so far failed to produce a solution."It sets off the protectionist fears that had been lying dormant," said Hogan.— CNN's Jeremy Diamond contributed to this report.The-CNN-Wire? & ? 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved. 3547

VISTA (CNS) - A delusional man who fatally shot a 23-year-old female acquaintance in unincorporated Escondido because he thought she and others were trying to kidnap him pleaded guilty today to voluntary manslaughter.Paul R. Castro IV, 28, will be sentenced to 21 years in state prison on June 15.Castro was on a five-day methamphetamine binge and suffering from paranoid delusions when he shot Antonia Herrera -- the girlfriend of his best friend -- and dumped her body in the 27600 block of Champagne Boulevard near the Lawrence Welk Resort, said Deputy District Attorney Keith Watanabe.A resident on a walk discovered Herrera's body on an embankment on Jan. 12, 2017.Castro -- a documented gang member from Las Vegas -- was arrested there a month later and brought back to San Diego to face charges. 810

VISTA, Calif. (KGTV) - Prosecutors presented evidence Thursday against a man suspected of killing his girlfriend in Cardiff in an effort to send the case to trial. Late in the day, a judge decided there was enough evidence for the case to move forward.Henry Cowen is charged with murder in the death of 43-year-old Sabrina Lukosky. During his preliminary hearing in Vista court, attorneys heard from multiple witnesses, including a DNA expert who tied Cowen to the crime scene. Lukosky’s mother requested a welfare check in October 2019 after not hearing from her daughter for several days. RELATED: North County man accused of killing girlfriend tried to escape the country, prosecutors sayOfficers found Lukosky’s car in front of the granny flat she shared with Cowen and reported a foul smell coming from the home. A search warrant was executed a few days later, and led to the discovery of Lukosky’s body. Police said there were signs of a violent struggle in the couple’s bedroom. "There was a broken stick, a bottle that had been broken, some amount of blood, and the victim had a 1.5-inch vertical gash to her forehead," said Deputy District Attorney Marnie Layon. The San Diego County Medical Examiner’s office later determined Lukosky died of blunt force trauma and strangulation. Prosecutors believe Cowen left San Diego County and traveled to Los Angeles, then took a Lyft to Riverside County. They also said Cowen tried to leave the country with the help of his children’s mother. RELATED: Friends remember Encinitas woman, police say, was killed by her boyfriendThe Fugitive Task Force arrested Cowen in Riverside County on Oct. 11. He has a criminal record including assault, kidnapping, and torture, authorities told 10News. 1747

WASHINGTON -- A veteran who lost his genitals due to a blast in Afghanistan has received the world’s most extensive penis transplant, according to the Associated Press.Surgeons at John Hopkins University said they wanted to address “an unspoken injury of war” by rebuilding the man’s entire pelvic region, transplanting a penis, scrotum and part of an abdominal wall from a deceased donor.In total, officials with the hospital said the surgery took 14 hours.Such transplants "can help those warriors with missing genitalia just as hand and arm transplant transformed the lives of amputees," Dr. W.P. Andrew Lee, Hopkins' chairman of plastic and reconstructive surgery.The patient, who asked to keep his identity hidden, is expected to regain urinary and sexual function.The scrotum transplant didn’t include the donor’s testicles, so reproduction won’t be possible.Three other successful penis transplants have been performed. Two in South Africa and one at Massachusetts General Hospital.For functionality, surgeons had to connect nerves and blood vessels. Hopkins is now screening additional veterans to see if any are good candidates for this type of reconstructive transplant.In a statement, Hopkins says the patient was quoted as saying: "When I first woke up, I felt finally more normal." 1302

WASHINGTON — U.S. health officials have started two new studies to test various blood thinners to try to prevent strokes, heart attacks, blood clots and other complications in COVID-19 patients.Doctors increasingly are finding blood clots throughout the bodies of many people who died from COVID-19 along with signs of damage they do to kidneys, lungs, blood vessels, the heart and other organs.National Heart, Lung and Blood Institute Director Gary Gibbons says that hospitals have been giving seriously ill patients anti-clotting drugs to try to prevent this, but “quite frankly, we didn’t know how best to treat it” in terms of which drugs or doses to use and at what stage of illness.The National Institutes of Health will coordinate a study in hospitalized patients comparing low and regular doses of the blood thinner heparin. The study will involve more than 100 sites around the world participating in a research effort with various governments, drug companies, universities and others to speed coronavirus therapies.A second study in COVID-19 patients not sick enough to need hospitalization will test various strategies against placebo pills: baby aspirin or low or regular doses of the anti-clotting drug apixaban, sold as Eliquis in the United States. The goal there is preventing blood clots or hospitalization.A third study starting later will test blood thinners for people who have recovered and no longer test positive for the coronavirus. Evidence is building that they may remain at higher risk for blood clots. 1538